Selvita Team Grows to Over 250 People
News Aug 11, 2015
Selvita has been intensively expanding its operations. The total employment at Selvita increased to 261 people, including 86 PhDs in August.
The period of 2014-2015 marks a significant increase for Selvita in terms of revenue and operations, both in its drug discovery outsourcing segment as well in the internal pipeline.
The company has recently signed several large and long-term services contracts in the area of medicinal and analytical chemistry with some of the most renowned pharma companies.
Selvita has also been successively expanding its capabilities in terms of proteomics, which has effected in establishing new collaborations also in this area.
The employment has been increasing accordingly, from 173 people in 2013, to 230 at the end of 2014.
Selvita is continuously investing in new laboratory infrastructure and highly qualified scientific staff, aiming to provide best quality integrated drug discovery services to pharmaceutical and biotechnology companies.
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019